Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Ryan O'Rourke

Orthopaedic Surgery South Bend, IN Medical Doctor

NPI 1801244827 CMS profile 2707318

1815 E Ireland Rd, South Bend, IN 46614

Open in the dashboard

General payments

$29,390

178 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Ryan O'Rourke of South Bend, IN is reported in the CMS Open Payments database as having received $29,390 across 178 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 84th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,470 17
2024 General $4,285 31
2023 General $5,480 37
2022 General $8,064 28
2021 General $6,998 22
2020 General $71 1
2019 General $3,022 42

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ryan O'Rourke
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Ryan O'Rourke were reported at $1,470. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Ryan O'Rourke Orthopaedic Surgery median Middle half National median
2019 $3,022 $644 $140–$2,844 $163
2020 $71 $312 $75–$1,860 $114
2021 $6,998 $520 $117–$2,495 $132
2022 $8,064 $598 $128–$2,731 $149
2023 $5,480 $461 $128–$2,264 $160
2024 $4,285 $497 $134–$2,475 $164
2025 $1,470 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Smith+Nephew, Inc. $20,260 52 payments
  2. Stryker Corporation $3,108 40 payments
  3. Zimmer Biomet Holdings, Inc. $2,474 47 payments
  4. Wardlow Enterprises $1,765 2 payments
  5. DePuy Synthes Sales Inc. $555 9 payments
  6. Heron Therapeutics, Inc. $275 3 payments
  7. Flexion Therapeutics, Inc. $217 11 payments
  8. Medacta USA, Inc. $180 3 payments
  9. Goode Surgical Inc $164 1 payment
  10. Vertex Pharmaceuticals Incorporated $122 1 payment
  11. Other $271 9 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Education $14,030 7 payments
  2. Food and Beverage $8,684 141 payments
  3. Travel and Lodging $6,676 30 payments
Products named General payments · program years 2019–2025
  1. OR3O Dual Mobility $4,883 14 payments
  2. JOURNEY $4,800 13 payments
  3. RI Hip Navigation $4,800 13 payments
  4. JOURNEY II Recon Knees $3,113 19 payments
  5. LEGION Revision $2,300 11 payments
  6. REAL INTELLIGENCE $1,898 19 payments
  7. POLARSTEM $1,760 5 payments
  8. TANDEM $1,729 8 payments
  9. MAKO $1,182 10 payments
  10. JOURNEY II Recon Knees $983 1 payment
  11. Other $6,987 124 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

188

Median for Orthopedic Surgery: 203

Drug cost

$1,241

Median for Orthopedic Surgery: $1,433

Branded share of claims

11.7%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Celecoxib Generic 24 $480
Doxycycline Hyclate Generic 19 $250
Meloxicam Generic 66 $168
Naproxen Generic 15 $95
Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim Brand 22 $89
Tramadol Hcl Generic 27 $80
Oxycodone Hcl Generic 15 $78

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 53 billing codes

Paid by Medicare

$67,106

Of which drugs: $2,314

Medicare patients

204

Average age 74

Services billed

2,292

136 women, 68 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 74%
Diabetes 30%
Depression 27%
Ischemic heart disease 23%
Chronic kidney disease 19%
Atrial fibrillation 18%
Osteoporosis 17%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, methylprednisolone acetate, 1 mg J1010 Office 14 1,400 $143
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 20 116 $78

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

178 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Indiana

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record